Genetic and Pharmacologic Targeting of STAT5/Gab2/PI3K/mTOR Signaling in a Mouse Myeloproliferative Disease Model

被引：0
|
作者：
Li, Geqiang [1 ]
Wang, Zhengqi [1 ]
Miskimen, Kristy L. [1 ]
Xie, Xiu Yan
Tse, William [2 ]
Gouilleux, Fabrice [3 ]
Moriggl, Richard [4 ]
Bunting, Kevin D. [1 ]
机构：
[1] Case Western Reserve Univ, Dept Med Hematol Oncol, Cleveland, OH 44106 USA
[2] Univ Colorado, Dept Med Hematol Oncol, Aurora, CO USA
[3] INSERM, U925, Amiens, France
[4] Ludwig Boltzman Inst Canc Res, Vienna, Austria
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1501 / 1501
页数：1
相关论文
共 50 条
  • [1] Targeting PI3K/mTOR signaling in cancer
    Arcaro, Alexandre
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [2] Targeting PI3K/mTOR Signaling in Cancer
    Emerling, Brooke M.
    Akcakanat, Argun
    CANCER RESEARCH, 2011, 71 (24) : 7351 - 7359
  • [3] Critical Role of the Gab2/PI3K/mTOR Pathway in the Pathogenesis of Ptpn11 (Shp2) Mutation-Induced Myeloproliferative Disease.
    Liu, Wei
    Liu, Xia
    Qu, Cheng-Kui
    BLOOD, 2012, 120 (21)
  • [4] Targeting oncogenic STAT3 and STAT5 signaling with on 146040, a small molecule inhibitor of PI3K α/δ and BCR-ABL.
    Cosenza, Stephen
    Panda, Gayatri
    Subbaiah, D. R. C. Venkata
    Akula, Balireddy
    Maillreddigari, Muraildhar
    Pallela, Venkat
    Reddy, M. V. Ramana
    Reddy, E. Prekumar
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [5] Targeting PI3K/mTOR signaling in cutaneous angiosarcoma
    Wada, M.
    Horinaka, M.
    Sakai, T.
    Masuzawa, M.
    Katoh, N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 : S56 - S56
  • [6] Targeting PI3K/Akt/mTOR signaling in cancer
    Porta, Camillo
    Paglino, Chiara
    Mosca, Alessandra
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [7] DUAL TARGETING OF PI3K AND mTOR SIGNALING IN MEDULLOBLASTOMA
    Clymer, Jessica
    Eckerdt, Frank
    Bell, Jonathan
    Lulla, Rishi
    Goldman, Stewart
    Platanias, Leonidas
    NEURO-ONCOLOGY, 2016, 18 : 112 - 112
  • [8] Physiologically significant genetic interaction between STAT5 and Gab2 during normal and pathologic hematopoiesis
    Li, Geqiang
    Wang, Zhengqi
    Zhang, Yi
    Haviemikova, Eleonora
    Tse, William
    Bunting, Kevin D.
    BLOOD, 2007, 110 (11) : 34A - 35A
  • [9] Targeting the PI3K/AKT/mTOR Signaling Pathway in Medulloblastoma
    Dimitrova, V.
    Arcaro, A.
    CURRENT MOLECULAR MEDICINE, 2015, 15 (01) : 82 - 93
  • [10] PKA and GAB2 play central roles in the FSH signaling pathway to PI3K and AKT in ovarian granulosa cells
    Hunzicker-Dunn, Mary E.
    Lopez-Biladeau, Blanca
    Law, Nathan C.
    Fiedler, Sarah E.
    Carr, Daniel W.
    Maizels, Evelyn T.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (44) : E2979 - E2988
12345